Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed May 12, 2022 · 10-Q · 42 days after period end · 0001640334-22-000949
| Metric | Q1 2022 | Q1 2021 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$1.97M | -$1.70M | -$556.90K | -$277.06K |
| EPS Diluted | — | — | -$0.32 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 12, 2022 · 42 d after period end
